Annual Review

22.12.2004

After eighteen years, Creative Lynx marked the end of 2004 with their most successful year to date. Their existing client base has been strengthened with several high profile account wins, the launch of a new office in Geneva and an extensive recruitment campaign.

Most recently, within the pharmaceutical sector, Creative Lynx have been appointed by Wyeth Pharmaceuticals to rebrand Tazocin, an intravenous antibiotic used in moderate and serious hospital-acquired infections such as MRSA. The campaign involves an integrated creative solution across the promotional platform including advertising material, sales literature and digital media. The win reflects Creative Lynx's extensive experience within the pharmaceutical industry, enjoying relationships with Serono International, Fresenius Kabi and Colgate-Palmolive.

Throughout 2004 Creative Lynx have sought to provide complete integrated creative solutions for their clients. This commitment has been rewarded with a number of design effectiveness awards.

Next Item